BioCentury
ARTICLE | Distillery Techniques

Assays and screens

January 2, 2018 9:59 PM UTC

A low-cost computational method for quantifying tumor cfDNA could identify cancer patients eligible for high-cost, whole-exome sequencing-based personalized medicine. The method quantifies tumor cfDNA...